first proposed that FOXD3-AS1 was down-regulated in NSCLC tissues and H1299, NCI-H460, A549 and L9981 cell lines, while FOXD3-AS1 levels were inversely correlated with aggressive lymph node metastasis and tumor grade (25). This evidence concerns the gene FOXD3 and non-small cell lung carcinoma.